ArticleJournal of medicinal chemistry2019

Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.

Cody J Lensing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.